Semnur Pharmaceuticals (SMNR) Research & Development (2024 - 2026)
Semnur Pharmaceuticals' Research & Development came in at $1.25 million for Q2 2026, up 148.8% from $502,000 a year earlier but down 1.3% from the prior quarter.
Powered by 
Analysis
Semnur Pharmaceuticals (SMNR) Research & Development (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Semnur Pharmaceuticals reported Research & Development of $4.37 million, up 277.9% year-over-year; for FY2025, it was $2.55 million, up 49.0% from FY2024.
- Going back by year, Research & Development was $1.71 million in FY2024.
- The five-year range for quarterly Research & Development is $187,000 (Q1 2025) to $1.27 million (Q1 2026).
- Year-over-year, Research & Development has increased for four consecutive quarters, with growth averaging 330.0% over the last four quarters.
- Business Quant data shows SMNR's Research & Development at $1.27 million (Q1 2026), $714,000 (Q4 2025) and $1.14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Semnur Pharmaceuticals | 85.18 Mn | 84.92 Mn | - | 1.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 714,000.00 |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 502,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 235,000.00 |
| Sep 30, 2024 | 233,000.00 |
API Access
Semnur Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SMNR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SMNR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SMNR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();